U.S. Markets closed

Edwards Lifesciences earnings rise

Oct 28 (Reuters) - Edwards Lifesciences Corp on Monday reported higher third-quarter earnings on strong sales of its artificial heart valves that are implanted without major invasive surgery.

Third-quarter net income was $77 million, or 68 cents per share, compared with $69 million, or 58 cents per share, a year earlier.

Analysts on average had expected 66 cents per share, according to Thomson Reuters I/B/E/S.